220 related articles for article (PubMed ID: 37045996)
21. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
Rekhtman N; Ang DC; Riely GJ; Ladanyi M; Moreira AL
Mod Pathol; 2013 Oct; 26(10):1307-19. PubMed ID: 23619604
[TBL] [Abstract][Full Text] [Related]
22. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
[TBL] [Abstract][Full Text] [Related]
23. Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern.
Yang F; Dong Z; Shen Y; Shi J; Wu Y; Zhao Z; Jiang G; Song X
Lung Cancer; 2020 Sep; 147():187-192. PubMed ID: 32721653
[TBL] [Abstract][Full Text] [Related]
24. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
25. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.
Zhang J; Fujimoto J; Zhang J; Wedge DC; Song X; Zhang J; Seth S; Chow CW; Cao Y; Gumbs C; Gold KA; Kalhor N; Little L; Mahadeshwar H; Moran C; Protopopov A; Sun H; Tang J; Wu X; Ye Y; William WN; Lee JJ; Heymach JV; Hong WK; Swisher S; Wistuba II; Futreal PA
Science; 2014 Oct; 346(6206):256-9. PubMed ID: 25301631
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
27. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
29. Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.
Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
[TBL] [Abstract][Full Text] [Related]
30. Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing.
Nahar R; Zhai W; Zhang T; Takano A; Khng AJ; Lee YY; Liu X; Lim CH; Koh TPT; Aung ZW; Lim TKH; Veeravalli L; Yuan J; Teo ASM; Chan CX; Poh HM; Chua IML; Liew AA; Lau DPX; Kwang XL; Toh CK; Lim WT; Lim B; Tam WL; Tan EH; Hillmer AM; Tan DSW
Nat Commun; 2018 Jan; 9(1):216. PubMed ID: 29335443
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.
Warth A; Muley T; Kossakowski C; Stenzinger A; Schirmacher P; Dienemann H; Weichert W
J Thorac Oncol; 2015 Apr; 10(4):638-44. PubMed ID: 25634008
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma.
Suzuki M; Nakatani Y; Ito H; Narimatsu H; Yamada K; Yoshioka E; Washimi K; Okubo Y; Kawachi K; Miyagi Y; Yokose T
Mod Pathol; 2018 Sep; 31(9):1404-1417. PubMed ID: 29785018
[TBL] [Abstract][Full Text] [Related]
35. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
[TBL] [Abstract][Full Text] [Related]
36. Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma.
Isaka T; Yokose T; Ito H; Nagata M; Furumoto H; Nishii T; Katayama K; Yamada K; Nakayama H; Masuda M
Medicine (Baltimore); 2015 Oct; 94(42):e1784. PubMed ID: 26496308
[TBL] [Abstract][Full Text] [Related]
37. Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations.
Kazdal D; Harms A; Endris V; Penzel R; Oliveira C; Kriegsmann M; Longuespée R; Winter H; Schneider MA; Muley T; Pfarr N; Weichert W; Stenzinger A; Warth A
Lung Cancer; 2018 Dec; 126():80-88. PubMed ID: 30527196
[TBL] [Abstract][Full Text] [Related]
38. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
[TBL] [Abstract][Full Text] [Related]
39. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
AbdulJabbar K; Raza SEA; Rosenthal R; Jamal-Hanjani M; Veeriah S; Akarca A; Lund T; Moore DA; Salgado R; Al Bakir M; Zapata L; Hiley CT; Officer L; Sereno M; Smith CR; Loi S; Hackshaw A; Marafioti T; Quezada SA; McGranahan N; Le Quesne J; ; Swanton C; Yuan Y
Nat Med; 2020 Jul; 26(7):1054-1062. PubMed ID: 32461698
[TBL] [Abstract][Full Text] [Related]
40. CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.
Perez-Johnston R; Araujo-Filho JA; Connolly JG; Caso R; Whiting K; Tan KS; Zhou J; Gibbs P; Rekhtman N; Ginsberg MS; Jones DR
Radiology; 2022 Jun; 303(3):664-672. PubMed ID: 35230187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
